每日一文(Aug 2001)

Aug 31,2001 Antisense therapy in oncology: new hope for an old idea?
There is a potential role for antisense oligonucleotides in the treatment of disease. The principle of antisense technology is the sequence-specific binding of an antisense oligonucleotide to target mRNA, resulting in the prevention of gene translation.
Aug 30,2001 Endothelin and Heart Failure
The availability of potent and orally active nonpeptide endothelin (ET) receptor antagonists has generated a host of information on the pathophysiolo-gical role of ET-1 in a number of preclinical models including hypertension, renal failure, heart failure and pulmonary hypertension.
Aug 29,2001 A new era in pyrogen testing
Pyrogens are substances (usually of biological origin) that cause fever after injection. The best-studied pyrogen is lipopolysaccharide (LPS, also known as endotoxin), found in the membrane of Gram-negative bacteria.
Aug 28,2001 Bone Builders: The Discoveries Behind Preventing and Treating Osteoporosis
Ask an actress to portray an old woman and chances are she’ll start by stooping over so she appears to have a curved spine, or “dowager's hump.” Until recently, such a posture was thought to be a frequent and inevitable consequence of a woman's aging. 
Aug 27,2001 IN PURSUIT OF MEANINGFUL LEARNING
How many of you have said to yourself or to your colleagues, “I want my students to understand physi-ology.”? The answer is obvious. We all want our students to understand physiology, not just memorize it. Or at least we all say we do. This paper will focus on what we need to do to help our students learn with understanding.
Aug 26,2001 Whole-cell biocomputing
The ability to manipulate systems on the molecular scale naturally leads to speculation about the rational design of molecular-scale machines. Cells might be the ultimate molecular-scale machines and our ability to engineer them is relatively advanced when compared with our ability to control the synthesis and direct the assembly of man-made materials.
Aug 25,2001 Germany Breaks New Ground in Stem Cell Treatment
BERLIN (Reuters) - A German hospital said on Friday it had successfully treated a heart patient using adult stem cells, a first for the medical world.
Aug 24,2001 INTERACTIONS BETWEEN MONOAMINES, GLUTAMATE, AND GABA IN SCHIZOPHRENIA
In spite of its proven heuristic value, the dopamine hypothesis of schizophrenia is now yielding to a multifactorial view, in which the other monoamines as well as glutamate and GABA are included, with a focus on neurotransmitter interactions in complex neurocircuits.
Aug 23,2001 Human Hypertension Caused by Mutations in WNK Kinases
Hypertension is a major public health problem of largely unknown cause. Here, we identify two genes causing pseudohypoaldosteronism type II, a Mendelian trait featuring hypertension, increased renal salt reabsorption, and impaired K+ and H+ excretion.
Aug 22,2001 Signal Transduction in Smooth Muscle
The mechanisms by which smooth muscle cells transduce external stimuli (e.g., pharmacological and mechanical) into functional responses have been the subject of investigation by many laboratories for decades. 
Aug 21,2001 XIAP-Apoptotic brake and promising therapeutic target
The X-linked Inhibitor of Apoptosis, XIAP, is a key mem-ber of the newly discovered family of intrinsic inhibitors of apoptosis (IAP) proteins. IAPs block cell death both in vitro and in vivo by virtue of inhibition of distinct caspases.
Aug 20,2001 Nitric oxide synthases- structure, function and inhibition
This review concentrates on advances in nitric oxide synthase (NOS) structure, function and inhibition made in the last seven years, during which time substantial advances have been made in our understanding of this enzyme family.
Aug 19,2001 Human Leukocyte Antigen Gene Polymorphism and the Histocompatibility Laboratory
The human leukocyte antigens (HLA) encoded by genes within the major histocompatibility complex display an impressive degree of polymorphism. This variability is apparently maintained in human populations through the need to successfully display a wide range of processed foreign peptides to the T cell antigen receptor.
Aug 18,2001 Molecules in focus - p73
The discovery of p73 as a family member of p53 has instigated a number of studies in search of its function, regulation, and involvement in tumorigenesis. p73 has been identified as a transcription factor that can regulate p53-dependent transcriptional targets.
Aug 17,2001 T cell homeostasis and systemic autoimmunity
It has recently been documented that survival and homeostasis of peripheral mature T cells depend on self-recognition.
Aug 16,2001 The immune tolerance network and rheumatic disease-Immune tolerance comes to the clinic
Autoimmune diseases pose some of the most baffling scientific questions and daunting clinical chal-lenges in internal medicine. With rare exception, we do not know what causes these diseases, and we have neither safe nor sufficiently effective therapies. 
Aug 15,2001 Dendritic Cells as Vectors for Therapy
Vaccines against infectious diseases are the success story of immunology. They have eradicated smallpox and spared countless people from tetanus, measles, polio, and hepatitis.
Aug 14,2001 Sports medicine
Sports medicine now comprises two main areas: the health benefits of regular physical activity and the health problems associated with sport and physical activity.
Aug 13,2001 Genes, Genetics, and Epigenetics- A Correspondence
Over the past months, as this special issue took shape, the Editors of Science have monitored an exchange of seven letters initiated by three queries from M. Bacon. These queries concern the popular definitions of "genes," "genetics," and "epigenetics."
Aug 12,2001 GENE THERAPY FOR DIABETES (Figure)
The focus of this review is on how gene therapy can be used in beta cell replacement strategies. Gene transfer to beta cells as well as recent advances in beta cell growth and development will be discussed.
Aug 11,2001 Intrinsic errors in genome annotation
Genome sequencing is usually followed by routine annotation of protein function based on the assumption that similar sequences will have similar functions. Here, we introduce a simple calculation to estimate the magnitude of any possible annotation errors.
Aug 10,2001 Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse
The level of cellular and molecular complexity of the nervous system creates unique problems for the neuroscientist in the design and implementation of functional genomic studies. Microarray technologies can be powerful, with limitations, when applied to the analysis of human brain disorders.
Aug 9,2001 Faster, better, cheaper genotyping
Scanning the genome for subtle genetic variations across thousands of individuals may help researchers find genes that underpin susceptibility to common diseases. Marina Chicurel considers the technological requirements.
Aug 8,2001 Signaling pathways in apoptosis as potential targets for cancer therapy
Apoptotic pathways might be significantly altered in cancer cells relative to untransformed cells, and these differences might present a therapeutic window that can be exploited for development of cancer drugs.
Aug 7,2001 Image metrics in the statistical analysis of DNA microarray data
In this paper, we perform statistical analysis on images of microarrays and show that quanti-tating the amount of fluorescent DNA bound to microarrays is subject to considerable uncertainty because of large and small-scale intensity fluctuations within spots, nonadditive background, and fabrication artifacts.
Aug 6,2001 Progress in cancer vaccines by enhanced self-presentation
The balance between immunity and tolerance is regulated at the immunologic synapse between T cells and specialized bone marrow-derived dendritic cells that present antigens to T cells.
Aug 5,2001 Trace amines: Identification of a family of mammalian G protein-coupled receptors
Tyramine, b-phenylethylamine, tryptamine, and octopamine are biogenic amines present in trace levels in mammalian nervous systems. Although some ‘‘trace amines’’ have clearly defined roles as neurotransmitters in invertebrates, the extent to which they function as true neurotransmitters in vertebrates has remained speculative.
Aug 4,2001 Drug discovery-an operating model for a new era
Despite the advent of new science and technologies, drug developers will need to make radical changes in their operations if they are to remain competitive and innovative
Aug 3,2001 Autoimmune Disease: Why and where it occurs
Here we adopt the view that all autoimmune diseases are initiated by response to a single antigen, which may or may not be restricted to a single organ. later in the disease, the response usually broadens, by a process called determinant spreading, to include other parts of the same molecule and other antigens in the same tissue.
Aug 2,2001 Next generation therapeutics-Human antibodies as next generation therapeutics
Antibodies and antibody derivatives constitute twenty five percent of therapeutics currently in development, and a number of therapeutic monoclonal antibodies have recently reached the market. All antibodies approved by the US Food and Drug Administration, however, contain mouse protein sequences. These partially murine antibodies, therefore, have the potential to elicit allergic or other complications when used in human patients. Recent developments aim to reduce or eliminate murine components, and fully human antibodies are rapidly becoming the norm. A number of technologies exist which enable the development of 100% human antibodies.
Aug 1,2001 Protein technologies -Protein interaction databases
Life depends on the interaction of proteins. The availability of the complete human genome sequence has highlighted the need for a tool to analyse protein interactions and several databases have been compiled for this purpose. These databases document, categorize, and analyze interacting proteins and the cellular functions of the interactions.

更新于2001-08-31